Clinical Trial Update: Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)

View source ↗

Summary

The IMPHROVE-D trial reports improvement of portal hypertension in patients with hepatitis D during viral suppression; the study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Hepatitis D
• Liver Cirrhosis
• Portal Hypertension

Snippet

Sponsor: Hannover Medical School | Conditions: Hepatitis D, Hepatitis B | Status: ACTIVE_NOT_RECRUITING